Journal articles
Keoshkerian E; Hunter M; Cameron B; Nguyen N; Sugden P; Bull R; Zekry A; Maher L; Seddiki N; Zaunders J, 2016, 'Hepatitis C-specific effector and regulatory CD4 T-cell responses are associated with the outcomes of primary infection', Journal of Viral Hepatitis, vol. 23, pp. 985 - 993, http://dx.doi.org/10.1111/jvh.12576
Hajarizadeh B; Lamoury FMJ; Feld JJ; Amin J; Keoshkerian E; Matthews GV; Hellard M; Dore GJ; Lloyd AR; Grebely J, 2016, 'Alanine aminotransferase, HCV RNA levels and pro-inflammatory and pro-fibrogenic cytokines/chemokines during acute hepatitis C virus infection', Virology Journal, vol. 13, http://dx.doi.org/10.1186/s12985-016-0482-x
Lamoury FMJ; Hajarizadeh B; Keoshkerian E; Feld JJ; Amin J; Teutsch S; Matthews GV; Hellard M; Dore GJ; Lloyd AR, 2016, 'HIV infection is associated with higher levels of monocyte chemoattractant protein-1 and eotaxin among people with recent hepatitis C virus infection', BMC Infectious Diseases, vol. 16, http://dx.doi.org/10.1186/s12879-016-1567-2
Marsden V; Donaghy H; Bertram KM; Harman AN; Nasr N; Keoshkerian E; Merten S; Lloyd AR; Cunningham AL, 2015, 'Herpes simplex virus type 2-infected dendritic cells produce TNF-α, which enhances CCR5 expression and stimulates HIV production from adjacent infected cells', Journal of Immunology, vol. 194, pp. 4438 - 4445, http://dx.doi.org/10.4049/jimmunol.1401706
Huang S; Herbert C; Keoshkerian E; Lloyd A; Thomas PS, 2013, 'IFN-gamma LEVELS IN EXHALED BREATH CONDENSATE AND PERIPHERAL BLOOD OF SARCOIDOSIS PATIENTS REFLECT AN IMMUNE PARADOX', RESPIROLOGY, vol. 18, pp. 48 - 48, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000315589700177&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
Huang S; Herbert C; Keoshkerian E; Lloyd A; Thomas PS, 2013, 'PROPORTION OF T REGULATORY CELLS IN THE PERIPHERAL BLOOD OF SARCOIDOSIS PATIENTS', RESPIROLOGY, vol. 18, pp. 48 - 48, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000315589700176&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
Nguyen N; Luciani F; Cameron B; Keoshkerian E; Zekry A; Lloyd A, 2012, '801 T CELLS CO-EXPRESSING CCR2, CCR5, CXCR3, AND CXCR6 ARE PREFERENTIALLY ENRICHED IN THE HCV-INFECTED LIVER', Journal of Hepatology, vol. 56, pp. S313 - S313, http://dx.doi.org/10.1016/S0168-8278(12)60813-7
Kelleher AD; Puls RL; Bebbington M; Boyle D; Ffrench R; Kent SJ; Kippax S; Purcell DFJ; Thomson S; Wand H, 2006, 'A randomized, placebo-controlled phase I trial of DNA prime, recombinant fowlpox virus boost prophylactic vaccine for HIV-1', AIDS, vol. 20, pp. 294 - 297, http://dx.doi.org/10.1097/01.aids.0000199819.40079.e9
Keoshkerian E; Happel KI; Lockhart EA; Mason CM; Poretta E; Odden AR; Nelson S; Ramsay AJ, 2005, 'Pulmonary interlukin-23 gene delivery increases local T-cell immunity and controls growth of Mycobacterium tuberculosis in the lungs.', Infectious Immunology, vol. 73, pp. 5782 - 5788
Chen K; Chen L; Zhao P; Marrero L; Keoshkerian E; Ramsay A; Cui Y, 2005, 'FL-CTL assay: Fluorolysometric determination of cell-mediated cytotoxicity using green fluorescent protein and red fluorescent protein expressing target cells', Journal of Immunological Methods, vol. 300, pp. 100 - 114, http://dx.doi.org/10.1016/j.jim.2005.02.010
Keoshkerian E; Ashton LJ; Smith DG; Ziegler JB; Kaldor JM; Cooper DA; Stewart GJ; Ffrench RA, 2003, 'Effector HIV-Specific Cytotoxic T-Lymphocyte Activity in Long-Term Nonprogressors: Associations With Viral Replication and Progression', Journal of Medical Virology, vol. 71, pp. 483 - 491, http://dx.doi.org/10.1002/jmv.10525
Keoshkerian E; Hicks C; Lindeman R, 2001, 'Adenoviral mediated IL-2 gene transfer to human long-term bone marrow stromal cultures.', Cancer Biotherapy and Radiopharmaceuticals, vol. 16, pp. 537 - 542
Keoshkerian E; Hicks C; Gaudry L; Lindeman R, 2000, 'B7.1 (CD80) expression on human acute myeloid leukaemia cells cultured with GM-CSF, IL-3, and IL-6.', Cancer Immunology and Immunotherapy, vol. 50, pp. 173 - 180
Minter AJ; Keoshkerian E; Chesterman CN; Dawes J, 1996, 'Fibroblast growth factor and heparin protect endothelial cells from the effects of interleukin 1', Journal of Cellular Physiology, vol. 167, pp. 229 - 237, http://dx.doi.org/10.1002/(SICI)1097-4652(199605)167:2<229::AID-JCP6>3.0.CO;2-R
